|
Derivative Contracts (Details) (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2013
|
Dec. 31, 2012
|
||||
|---|---|---|---|---|---|---|
|
Pharmsynthez [Member]
|
||||||
| Derivative financial instruments: | ||||||
| Derivative asset, fair value | $ 6,795 | $ 0 | ||||
|
Neovasc common stock options/warrants [Member]
|
||||||
| Derivative financial instruments: | ||||||
| Derivative asset, fair value | 2,319 | 1,872 | ||||
|
Embedded conversion option [Member]
|
||||||
| Derivative financial instruments: | ||||||
| Derivative liability, fair value | 74,079 | 0 | ||||
|
Forward contracts [Member]
|
||||||
| Derivative financial instruments: | ||||||
| Derivative liability, fair value | $ 2,242 | [1] | $ 1,294 | [1] | ||
|
||||||